ArticleCellular and molecular life sciences : CMLS2023

Network-informed discovery of multidrug combinations for ERα+/HER2-/PI3Kα-mutant breast cancer.

Dina Hany et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.